register

Medical and Science

AusDoc’s digital transformation to facilitate new doctor connections

Health Industry Hub | December 10, 2020 |

Medical News: AusDoc, Australia’s leading medical news information publisher has released a set of new features that will allow doctors to connect and collaborate with colleagues.

In an Australian first, AusDoc will enable doctors to connect with other medical practitioners and communicate safely using an end-to-end encrypted messaging system.

Doctors will also be able to follow their preferred authors and have access to all globally published research via a new PubMed integration personalised to their interest areas.

Australian Doctor Group’s Managing Director Bryn McGeever says the new features available on AusDoc platform enable doctors to better connect, communicate and collaborate with colleagues, peers and specialists, as well as the wider pharmaceutical industry.

“This week, AusDoc has become much more than a website that keeps doctors informed with all the latest news, opinion, clinical updates, and education,” he commented.

“We believe that medicine will become even more collaborative in the future than it is today and that a connected community – where doctors can stay up-to-date, and share experiences – will benefit all.”

“With one eye on the ever-evolving communication needs of doctors, ADG has been investing heavily in data and digital capabilities for the past decade, and more recently we have accelerated our digital and product investment by more than $2M this year alone. We are evolving to become a place where doctors can now connect and collaborate with colleagues.”

ADG will look to continue its digital investment with the anticipated launch of a mobile app in early 2021.


News - MedTech & Diagnostics

Roche unlocks new horizons for genomic research in Asia Pacific

Roche unlocks new horizons for genomic research in Asia Pacific

Health Industry Hub | November 9, 2026 |

Roche is advancing its next-generation sequencing (NGS) ambitions in Asia Pacific following the global launch of AXELIOS 1 in June […]

More


News - Pharmaceuticals

'Unexpected and Surprising': Novartis’ Lp(a) setback raises tough questions for Amgen and Lilly - Professor Stephen Nicholls, Victorian Heart Hospital

‘Unexpected and surprising’: Novartis Lp(a) setback raises tough questions for Amgen and Lilly

Health Industry Hub | November 9, 2026 |

The failure of Novartis’ lipoprotein(a) [Lp(a)] therapy to translate substantial biomarker reductions into meaningful cardiovascular benefits has been met with […]

More


News - MedTech & Diagnostics

More public hospitals turn to same-day hip and knee surgery but recovery risks persist

More public hospitals turn to same-day hip and knee surgery, but key blind spots persist

Health Industry Hub | November 9, 2026 |

Same-day hip and knee replacements to ease surgical waiting lists are being trialled at The Royal Adelaide Hospital (RAH), but […]

More


News - Pharmaceuticals

TGA approves oral Wegovy, prompting questions over efficacy and clinical positioning

TGA approves oral Wegovy, prompting questions over efficacy and clinical positioning

Health Industry Hub | November 9, 2026 |

The Therapeutic Goods Administration (TGA) approval of Novo Nordisk’s oral GLP-1 receptor agonist Wegovy (semaglutide) is introducing a new dimension to […]

More


This content is copyright protected. Please subscribe to gain access.